Homepage
Medication Guide
What Are the Side Effects of Zongertinib?
Zongertinib is a kinase inhibitor that targets activating mutations in the tyrosine kinase domain of HER2 (ERBB2). It is used for the treatment of unresectable or metastatic non-squamous non-small cel...
514
Sunday, September 28th, 2025, 16:38
Precautions for Zongertinib Administration
Zongertinib is a kinase inhibitor that targets activating mutations in the tyrosine kinase domain of HER2 (ERBB2). It is indicated for the treatment of adult patients with unresectable or metastatic n...
519
Sunday, September 28th, 2025, 16:27
How to Use Zongertinib
Zongertinib is a novel kinase inhibitor indicated for the treatment of adult patients with unresectable or metastatic non-squamous non-small cell lung cancer (NSCLC) harboring activating mutations in ...
514
Sunday, September 28th, 2025, 16:24
Indications of Zongertinib
Zongertinib is a novel kinase inhibitor recently granted accelerated approval by the U.S. FDA. As a targeted therapeutic drug for specific patients with non-small cell lung cancer (NSCLC), key informa...
513
Sunday, September 28th, 2025, 16:20
How to Purchase Zongertinib
Zongertinib is a targeted therapeutic drug for non-small cell lung cancer (NSCLC) harboring activating mutations in the tyrosine kinase domain of HER2 (ERBB2). Due to its specificity and potential eff...
512
Sunday, September 28th, 2025, 16:15
What Are the Side Effects of Cemiplimab?
Cemiplimab is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of patients with metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC) who are not el...
510
Sunday, September 28th, 2025, 16:07
Indications of Cemiplimab
Cemiplimab is an important immunotherapeutic drug classified as a programmed death receptor-1 (PD-1) blocking antibody. As a major breakthrough in the field of cancer immunotherapy in recent years, th...
509
Sunday, September 28th, 2025, 15:50
How to Purchase Cemiplimab
Cemiplimab is a PD-1 inhibitor approved for the treatment of patients with metastatic or locally advanced cutaneous squamous cell carcinoma (CSCC) who are not eligible for curative surgery or curative...
510
Sunday, September 28th, 2025, 15:24
How to Use Emicizumab
Emicizumab is a bispecific antibody drug used for preventing bleeding in patients with hemophilia A.How to Use EmicizumabRoute of AdministrationEmicizumab is for subcutaneous injection only and must n...
517
Sunday, September 28th, 2025, 14:29
How to Purchase Emicizumab
Emicizumab is a bispecific antibody drug used for preventing bleeding in patients with hemophilia A. Due to its specific properties as a biological agent, it must be purchased through formal channels,...
510
Friday, September 26th, 2025, 15:26
115 / 221
2204 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved